Compare PDD & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDD | ABT |
|---|---|---|
| Founded | 2015 | 1888 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.5B | 152.9B |
| IPO Year | 2018 | 2006 |
| Metric | PDD | ABT |
|---|---|---|
| Price | $83.78 | $89.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 20 |
| Target Price | ★ $139.22 | $130.90 |
| AVG Volume (30 Days) | 7.5M | ★ 8.5M |
| Earning Date | 05-26-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $15.35 | $10.75 |
| Revenue Next Year | $12.63 | $8.10 |
| P/E Ratio | ★ $10.63 | $151.35 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $71.94 | $81.97 |
| 52 Week High | $139.41 | $137.49 |
| Indicator | PDD | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 42.55 |
| Support Level | $81.56 | $86.02 |
| Resistance Level | $107.53 | $89.34 |
| Average True Range (ATR) | 2.54 | 2.44 |
| MACD | 1.19 | -0.28 |
| Stochastic Oscillator | 76.49 | 6.30 |
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.